ATLASLiminatus Pharma (LIMN) earnings date: Nov 12, 2026
Liminatus Pharma (LIMN) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on LIMN
| Last price | $2.81 (+2.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.5% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Liminatus Pharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Liminatus Pharma reports on Nov 12, 2026. One email the day before, with ATLAS’s read on Liminatus Pharma. You can switch it off at any time.
Alert me before LIMN reportsFree to start. Creating an account takes under a minute.
Notify me when Liminatus Pharma reports
Track LIMN free Add Liminatus Pharma to a free ATLAS watchlist and see its next report date in one place.
LIMN earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Aug 14, 2026 · Miss |
| Beat rate (last 4 reports) | 1 of 4 (25%) |
| Average EPS surprise | -3.3% |
| Average move around a report | ±8.2% (last 4) |
| Sector | Healthcare · Biotechnology |
Liminatus Pharma earnings history: last 4 reports
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 14, 2026 | – | -$0.03 | – | Miss | -6.0% |
| Jan 23, 2026 | $1.61 | $1.87 | +16.2% | Beat | -8.8% |
| Oct 29, 2025 | $2.62 | $2.04 | -22.1% | Miss | -0.7% |
| Oct 1, 2025 | -$0.25 | -$0.26 | -4.0% | Miss | +17.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for LIMN
See the fair value, the probability range and the earnings history of Liminatus Pharma on its ATLAS page.
Liminatus Pharma (LIMN) stock analysisPlans from €3.99 a month.
Liminatus Pharma earnings: frequently asked questions
When does Liminatus Pharma (LIMN) report earnings?
Liminatus Pharma is scheduled to report on Thursday, November 12, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does LIMN beat earnings estimates?
Of its last 4 reports with a recorded result, Liminatus Pharma beat the EPS estimate 1 times; the average surprise was -3.3%. Past results do not predict the next one.
How much does LIMN move around earnings?
Over its last 4 reports the stock moved an average of 8.2% (absolute, from the close before the report day to the close after it), and finished higher 1 of 4 times.
How much does LIMN usually move in a day?
On a normal trading day the ATLAS model puts LIMN’s one-day range at about ±4.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer